April 2016 – Maojin & Ying’s NIH R01 on medulloblastoma TME started

8/15/2018

Congratulations to Drs. Maojin Yao and Ying Jiang for the start of a NIH R01 to study immunological tumor microenvironment in medulloblastoma - a job well done!